The firm also shared validation data at ASCO 2021 on its nasal swab classifier to help guide treatment decisions for patients with indeterminate lung nodules.
Veracyte to Acquire HalioDx for €260M
Veracyte said the acquisition will help accelerate its in vitro diagnostic test development and manufacturing operations in Europe.
OncoDNA Inks Contract With HalioDx to Expand Pharma Testing Services Into North America
HalioDx operates a CLIA-certified lab through which OncoDNA will provide it molecular testing services to drugmakers studying precision cancer therapies.
Jan 17, 2018
HalioDx Closes €18.5M Series B Round
Mar 23, 2015